Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Proposed Use of Continuous Glucose Monitoring for Care of Critically Ill COVID-19 Patients.

Proposed Use of Continuous Glucose Monitoring for Care of Critically Ill COVID-19 Patients. Journal of diabetes science and technology Jankovic, I., Basina, M. 2020: 1932296820965203

Abstract

Coronavirus disease 2019 (COVID-19) has disproportionately affected patients with diabetes. Mounting evidence has shown that adequate inpatient glycemic control may decrease the risk of mortality. In critically ill patients, insulin drips are the most effective means of controlling blood glucose. However, resource limitations such as the availability of protective equipment and nursing time have discouraged the use of insulin drips during COVID-19. In this commentary, we review existing evidence on the importance of glycemic control in COVID-19 patients with diabetes and propose a protocol for utilizing continuous glucose monitors (CGMs) to improve glycemic control by decreasing the need for bedside management in critically ill COVID-19 patients.

View details for DOI 10.1177/1932296820965203

View details for PubMedID 33084380